Alfred Hager1, Ruth Weber, Jan Müller, John Hess. 1. Department of Pediatric Cardiology and Congenital Heart Disease, Deutsches Herzzentrum München, Technische Universität München, Lazarettstr. 36, 80636, Munich, Germany, a-hager@web.de.
Abstract
OBJECTIVE: A single dose of sildenafil improves exercise capacity in Fontan patients. However, a recent study failed to show a long-term effect of sildenafil. This study evaluated whether there are factors that might predict sildenafil effects. METHODS: We studied 36 patients (16-42 years, 14 female) with univentricular heart after various modifications of the Fontan surgery (13 APC, 16 AVC, 7 TCPC). They performed two cardiopulmonary exercise tests, with at least 120 min rest and a single dose of 50 mg sildenafil in between. RESULTS: After sildenafil administration, patients improved their peak oxygen uptake from 64.5 to 67.3 % predicted (p = 0.0003) without change in ventilatory efficiency ([Formula: see text] slope), oxygen saturation (SpO2) at rest or at peak exercise, respiratory exchange ratio. In addition, resting systolic blood pressure was slightly reduced after sildenafil administration. There was a moderate negative correlation of this improvement to baseline peak oxygen uptake (r = -0.395; p = 0.017). The change in peak oxygen uptake could not be correlated to time of surgery, type of surgery, NT-pro-BNP, or to other clinical data. Nevertheless, all four patients with NT-pro-BNP levels higher than 1,000 pg/ml had the most prominent improvements in exercise capacity. CONCLUSIONS: Fontan patients have an improved exercise capacity after a single dose of sildenafil. Patients with worse baseline peak oxygen uptake profit more.
OBJECTIVE: A single dose of sildenafil improves exercise capacity in Fontan patients. However, a recent study failed to show a long-term effect of sildenafil. This study evaluated whether there are factors that might predict sildenafil effects. METHODS: We studied 36 patients (16-42 years, 14 female) with univentricular heart after various modifications of the Fontan surgery (13 APC, 16 AVC, 7 TCPC). They performed two cardiopulmonary exercise tests, with at least 120 min rest and a single dose of 50 mg sildenafil in between. RESULTS: After sildenafil administration, patients improved their peak oxygen uptake from 64.5 to 67.3 % predicted (p = 0.0003) without change in ventilatory efficiency ([Formula: see text] slope), oxygen saturation (SpO2) at rest or at peak exercise, respiratory exchange ratio. In addition, resting systolic blood pressure was slightly reduced after sildenafil administration. There was a moderate negative correlation of this improvement to baseline peak oxygen uptake (r = -0.395; p = 0.017). The change in peak oxygen uptake could not be correlated to time of surgery, type of surgery, NT-pro-BNP, or to other clinical data. Nevertheless, all four patients with NT-pro-BNP levels higher than 1,000 pg/ml had the most prominent improvements in exercise capacity. CONCLUSIONS: Fontan patients have an improved exercise capacity after a single dose of sildenafil. Patients with worse baseline peak oxygen uptake profit more.
Authors: Nazzareno Galiè; Hossein A Ghofrani; Adam Torbicki; Robyn J Barst; Lewis J Rubin; David Badesch; Thomas Fleming; Tamiza Parpia; Gary Burgess; Angelo Branzi; Friedrich Grimminger; Marcin Kurzyna; Gérald Simonneau Journal: N Engl J Med Date: 2005-11-17 Impact factor: 91.245
Authors: Gira S Morchi; D Dunbar Ivy; Mark C Duster; Lori Claussen; Kak-Chen Chan; Joseph Kay Journal: Congenit Heart Dis Date: 2009-04 Impact factor: 2.007
Authors: Hossein A Ghofrani; Robert Voswinckel; Frank Reichenberger; Horst Olschewski; Peter Haredza; Burcu Karadaş; Ralph T Schermuly; Norbert Weissmann; Werner Seeger; Friedrich Grimminger Journal: J Am Coll Cardiol Date: 2004-10-06 Impact factor: 24.094
Authors: Vitalie Faoro; Michel Lamotte; Gael Deboeck; Adriana Pavelescu; Sandrine Huez; Hervé Guenard; Jean-Benoît Martinot; Robert Naeije Journal: High Alt Med Biol Date: 2007 Impact factor: 1.981
Authors: Ryan J Butts; Carolyn T Spencer; Lanier Jackson; Martha E Heal; Geoffrey Forbus; Thomas C Hulsey; Andrew M Atz Journal: Pediatr Cardiol Date: 2014-09-02 Impact factor: 1.655
Authors: Sjoerd S M Bossers; Merih Cibis; Livia Kapusta; Wouter V Potters; Miranda M Snoeren; Jolanda J Wentzel; Adriaan Moelker; Willem A Helbing Journal: Pediatr Cardiol Date: 2016-01-12 Impact factor: 1.655